MSG606 TFA
MSG606 TFA is a selective melanocortin 1 receptor (MC1R) antagonist. MSG606 TFA can abolish the neuroprotective effects of BMS-470539 (HY-15616) (MC1R agonist). MSG606 TFA can inhibit cancer cell proliferation and transition from the G1 to the S phase. MSG606 TFA can delay pain hypersensitivity and reduce cholesterol levels. MSG606 TFA can be used for the researches of cancer, inflammation, neurological and metabolic disease, such as breast cancer and subarachnoid hemorrhage (SAH).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C62H82N20O13S.xC2HF3O2
- 分子量:1347.51 (free base)
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
MC1R |
MSG606 TFA (20 μM, 3 h) attenuates the NDP-MSH-stimulated increase in cAMP in T-47d and MCF7 cells[3].
MSG606 TFA (20 μM, 6 h) inhibits cell proliferation in NDP-MSH-stimulated T-47d and MCF7 cells[3].
MSG606 TFA (20 μM, 0-12 h) prolongs the time taken to transition from the G1 to the S phase in NDP-MSH-stimulated T-47d cells[3].
MSG606 TFA (5-20 μM, overnight) decreases CREB, ATF-1, the phosphorylation of ERK and p-65 NFκB levels in NDP-MSH-stimulated T-47d, MCF7 and HEK 293 T cells[3].
MSG606 TFA () inhibits the mRNA expression of IL-1β and TNFα in LPS ()-stimulated BMDMs[4].
MSG606 TFA (1 μmol/L, 30 mins) attenuates the oxLDL-induced increase in LXRα expression in BMDMs[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T-47d, MCF7 and HEK 293 T cells
-
Concentration:5, 10 and 20 μM
-
Incubation Time:Overnight
-
Result:Decreased CREB, ATF-1, the phosphorylation of ERK and p-65 NFκB levels
MSG606 TFA (7.5 μg, i.c.v) increases hyperalgesia latencies in Morphine-treated female mice[2].
MSG606 TFA (1 mg/kg, i.p., daily for 4 weeks) reduces total cholesterol levels and increases markers of plaque stability in mice with cholesterol-rich high-fat diet[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Subarachnoid hemorrhage (SAH) rats models[1]
-
Dosage:6 nM
-
Administration:Intracerebrally injection, 1 h befor SAH
-
Result:Increased levels of NFκB, IL-1β, and TNFα.
Reduced p-AMPK and p-TBK1.
-
Animal Model:Mice with cholesterol-rich high-fat diet[4]
-
Dosage:1 mg/kg
-
Administration:Intraperitoneally injection, daily for 4 weeks
-
Result:Reduced total cholesterol levels.
Increases markers of plaque stability.
increased hepatic ABCA1 and ABCG1 and LDL receptor mRNA levels.
Reduced monocyte counts in the aorta and modulates circulating monocyte profile.
化学情報
-
性状 Solid
-
分子量 1347.51 (free base)
-
分子式 C62H82N20O13S.xC2HF3O2
-
Color White to off-white
-
シーケンスの短縮
{Bua}GH-{d-Phe}-R-{d-Trp}-CDRFG-NH2 (Carba sulfide bridge:Bua1-Cys7)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Xu W, et al. Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats. Neurotherapeutics. 2020 Jan;17(1):294-308. [Content Brief]
[2]. Juni A, et al. Sex-specific mediaion of opioid-induced hyperalgesia by the melanocortin-1 receptor. Anesthesiology. 2010 Jan;112(1):181-8. [Content Brief]
[3]. Chelakkot VS, et al. MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. NPJ Precis Oncol. 2023 Sep 7;7(1):85. [Content Brief]
[4]. Rinne P, et al. Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages. Circulation. 2017 Jul 4;136(1):83-97. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)